SynthesisThe Lancet. Neurology2013

Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials.

William N Whiteley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.